IDiyas

For the Inventor, By the Inventor

Montagnola/Lugano, Switzerland

Matti Siren

USPTO Granted Patents = 25

Average Co-Inventor Count = 1.2

ph-index = 13

Forward Citations = 379(Granted Patents)


Location History:

  • 6596 Gordola, CH (1980)
  • CH-8002 Zurich, CH (1982)
  • CH-6596 Gordola, CH (1988)
  • CH-6926 Montagnola/Lugano, CH (1988 - 1989)
  • Lugano, CH (1991)
  • Montagnola/Lugano, CH (1988 - 1994)
  • Helsinki, FI (1993 - 1998)

Company Filing History:

goldMedal16 out of 124 
 
Perstorp Ab
 patents
silverMedal9 out of 832,718 
Other
 patents

Years Active: 1980-1998

Loading Chart...
25 patents (USPTO):Explore Patents
1. 5846957 - Use of an ester of inositoltrisphosphate for the preparing of medicaments (1998-12-08),
2. 5654280 - Pharmaceutical composition (1997-08-05),
3. 5342832 - Use of mono and di inositolphosphates for treating inflammation (1994-08-30),
4. 5330979 - Method of treating renal disorders with inositoltriphosphate (1994-07-19),
5. 5284839 - Use of inositoltrisphosphate to treat abnornal gastrointestinal motility (1994-02-08),
6. 5278332 - Derivatives of cyclohexane (1994-01-11),
7. 5274161 - Derivatives of cyclohexane (1993-12-28),
8. 5157140 - Esters of myo-inositol phosphate (1992-10-20),
9. 5135923 - Method of treating cardiovascular diseases (1992-08-04),
10. 5128332 - Method of treating cardiovascular diseases using inositoltrisphosphate (1992-07-07),
11. 5057507 - Method of alleviating bone damage with inositoltriphosphate (1991-10-15),
12. 5051411 - A method of achieving an immunosuppressive effect (1991-09-24),
13. 5023248 - Method of treating diabetes with inositol triphosphate (1991-06-11),
14. 5019566 - Method of treating inflammation with inositol triphosphate (1991-05-28),
15. 5015634 - Method of treating tissue damage with inositol triphosphate (1991-05-14),

Title: Innovator Matti Siren: Pioneering Pharmaceutical Advancements

Introduction

Matti Siren, based in Montagnola/Lugano, Switzerland, is a renowned inventor with a significant contribution to pharmaceutical innovations. With an impressive portfolio of 23 patents, his work primarily focuses on the use of novel compounds for the development of medicinal products aimed at improving human health.

Latest Patents

One of Siren's latest patents is centered on the "Use of an ester of inositoltrisphosphate for the preparing of medicaments." This patent describes a pharmaceutical composition that includes an active ingredient selected from a variety of compounds, including trisphosphorylated pentoses, pentitols, anhydropentitols, trisphosphorylated hexoses, hexitols, anhydrohexitols, and trisphosphorylated heptoses. The pharmaceutical composition also mentions the active ingredient can be administered in the form of a salt. Furthermore, his invention introduces a method for preventing or alleviating tissue damage in mammals, including humans, by administering an effective amount of the pharmaceutical composition.

Career Highlights

Throughout his career, Matti Siren has worked with notable companies such as Perstorp AB. His vast experience in these esteemed organizations has enabled him to refine his expertise in pharmaceutical research and development, culminating in groundbreaking innovations.

Collaborations

Siren has collaborated with prominent colleagues, including Lars Edvinsson and Bertil Lofkvist. These partnerships have undoubtedly played a crucial role in advancing pharmaceutical research and contributed to the successful development of his innovative products.

Conclusion

Matti Siren stands as a pivotal figure in the field of pharmaceuticals, with a rich history of patents that reflect his commitment to enhancing medical treatment options. His work continues to inspire future innovations in the medical field, showcasing the impact of dedicated inventors on the health and well-being of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…